Kevin McKernan

No, it's very important how you ingest it. Like most of these people are taking oils because they last longer in the body when you take them orally. Okay. But there are times – There's droplets on your tongue. Yeah. There are cases where you do have to vaporize it or smoke it because you can't keep food down. So putting an oil – An oral drug in comes right back up. So there's a place for both.

No, it's very important how you ingest it. Like most of these people are taking oils because they last longer in the body when you take them orally. Okay. But there are times – There's droplets on your tongue. Yeah. There are cases where you do have to vaporize it or smoke it because you can't keep food down. So putting an oil – An oral drug in comes right back up. So there's a place for both.

But that kind of put me into this a bit more of a, I'd say, anti-authoritarian scientist is that I was a little tired. Decentralized. Yes. This is when I started learning about Bitcoin. This is when I started learning about how the medical system is too centralized. They're not allowing us to use these new technologies to segregate the population into ways that are more intelligently treated.

But that kind of put me into this a bit more of a, I'd say, anti-authoritarian scientist is that I was a little tired. Decentralized. Yes. This is when I started learning about Bitcoin. This is when I started learning about how the medical system is too centralized. They're not allowing us to use these new technologies to segregate the population into ways that are more intelligently treated.

But that kind of put me into this a bit more of a, I'd say, anti-authoritarian scientist is that I was a little tired. Decentralized. Yes. This is when I started learning about Bitcoin. This is when I started learning about how the medical system is too centralized. They're not allowing us to use these new technologies to segregate the population into ways that are more intelligently treated.

Everything kind of gets centralized to the FDA. And even the concept of sequencing these tumors and drugging them independently was very controversial with the FDA. They wanted to go through 510K. So how would you go about doing this today if you wanted to do it? There are companies now that have kind of gone through the process with the FDA now that it's been decades.

Everything kind of gets centralized to the FDA. And even the concept of sequencing these tumors and drugging them independently was very controversial with the FDA. They wanted to go through 510K. So how would you go about doing this today if you wanted to do it? There are companies now that have kind of gone through the process with the FDA now that it's been decades.

Everything kind of gets centralized to the FDA. And even the concept of sequencing these tumors and drugging them independently was very controversial with the FDA. They wanted to go through 510K. So how would you go about doing this today if you wanted to do it? There are companies now that have kind of gone through the process with the FDA now that it's been decades.

But that's the problem is it took decades. So like, you know, Foundation Medicine, I think has they probably have a 510K by now. or using at least more FDA-approved tests, if you will. But they can sequence your tumors and give you a profile. I've used this with my father, actually. We profiled him at Foundation Medicine and at Johns Hopkins. to track his, you know, the progress of his tumor.

But that's the problem is it took decades. So like, you know, Foundation Medicine, I think has they probably have a 510K by now. or using at least more FDA-approved tests, if you will. But they can sequence your tumors and give you a profile. I've used this with my father, actually. We profiled him at Foundation Medicine and at Johns Hopkins. to track his, you know, the progress of his tumor.

But that's the problem is it took decades. So like, you know, Foundation Medicine, I think has they probably have a 510K by now. or using at least more FDA-approved tests, if you will. But they can sequence your tumors and give you a profile. I've used this with my father, actually. We profiled him at Foundation Medicine and at Johns Hopkins. to track his, you know, the progress of his tumor.

But I went down a rabbit hole there again. But just how did this get to the vaccine is that that put me into the cannabis space. And I've been since sequencing cannabis genomes to try to inputting their genomes public so that we can get all these genomes out of the patent tickets that exist on the Human Genome Project.

But I went down a rabbit hole there again. But just how did this get to the vaccine is that that put me into the cannabis space. And I've been since sequencing cannabis genomes to try to inputting their genomes public so that we can get all these genomes out of the patent tickets that exist on the Human Genome Project.

But I went down a rabbit hole there again. But just how did this get to the vaccine is that that put me into the cannabis space. And I've been since sequencing cannabis genomes to try to inputting their genomes public so that we can get all these genomes out of the patent tickets that exist on the Human Genome Project.

The Human Genome Project ended up with like over 4,000 patents on it for various genes. So like 20% of the genes in the human genome ended up being patented. And that made it so that people like Foundation Medicine had a really hard time sequencing kids' genomes to deploy these tools because it was a patent ticket trying to go through and sequence these things.

The Human Genome Project ended up with like over 4,000 patents on it for various genes. So like 20% of the genes in the human genome ended up being patented. And that made it so that people like Foundation Medicine had a really hard time sequencing kids' genomes to deploy these tools because it was a patent ticket trying to go through and sequence these things.

The Human Genome Project ended up with like over 4,000 patents on it for various genes. So like 20% of the genes in the human genome ended up being patented. And that made it so that people like Foundation Medicine had a really hard time sequencing kids' genomes to deploy these tools because it was a patent ticket trying to go through and sequence these things.

Well, what we did, knowing the experience we had on the Human Genome Project, and I'd spent a part of my career running a clinical diagnostic lab sequencing epilepsy kids and mitochondrial disease patients and autism kids as well. And we ran into the same problems.

Well, what we did, knowing the experience we had on the Human Genome Project, and I'd spent a part of my career running a clinical diagnostic lab sequencing epilepsy kids and mitochondrial disease patients and autism kids as well. And we ran into the same problems.

Well, what we did, knowing the experience we had on the Human Genome Project, and I'd spent a part of my career running a clinical diagnostic lab sequencing epilepsy kids and mitochondrial disease patients and autism kids as well. And we ran into the same problems.